Apotex Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for APOTEX, and what generic and branded alternatives to APOTEX drugs are available?
APOTEX has two hundred and ninety-one approved drugs.
There are eighteen tentative approvals on APOTEX drugs.
Summary for Apotex
| US Patents: | 0 |
| Tradenames: | 216 |
| Ingredients: | 209 |
| NDAs: | 291 |
| Patent Litigation for Apotex: | See patent lawsuits for Apotex |
| PTAB Cases with Apotex as petitioner: | See PTAB cases with Apotex as petitioner |
Drugs and US Patents for Apotex
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | RISPERIDONE | risperidone | TABLET;ORAL | 077953-004 | Sep 15, 2008 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Apotex Inc | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 077414-001 | Mar 7, 2006 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Apotex | PREGABALIN | pregabalin | CAPSULE;ORAL | 211685-008 | Jul 7, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Apotex | ALKERAN | melphalan | TABLET;ORAL | 014691-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | |||||
| Apotex | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 076140-002 | Sep 26, 2002 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Apotex Inc | OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 091572-001 | Oct 8, 2014 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Apotex
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Apotex | PAXIL | paroxetine hydrochloride | TABLET;ORAL | 020031-005 | Dec 29, 1992 | 6,063,927*PED | See Plans and Pricing |
| Apotex | PAXIL | paroxetine hydrochloride | TABLET;ORAL | 020031-004 | Dec 29, 1992 | 5,900,423*PED | See Plans and Pricing |
| Apotex | PAXIL | paroxetine hydrochloride | CAPSULE;ORAL | 020885-004 | Oct 9, 1998 | 6,080,759*PED | See Plans and Pricing |
| Apotex | PAXIL | paroxetine hydrochloride | TABLET;ORAL | 020031-003 | Dec 29, 1992 | 5,789,449*PED | See Plans and Pricing |
| Apotex | PAXIL | paroxetine hydrochloride | SUSPENSION;ORAL | 020710-001 | Jun 25, 1997 | 5,872,132*PED | See Plans and Pricing |
| Apotex | PAXIL | paroxetine hydrochloride | TABLET;ORAL | 020031-003 | Dec 29, 1992 | 5,872,132*PED | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for APOTEX drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Extended-release Tablets | 25 mg | ➤ Subscribe | 2005-09-09 |
| ➤ Subscribe | Oral Suspension | 10 mg/5 mL | ➤ Subscribe | 2005-02-10 |
| ➤ Subscribe | Extended-release Tablets | 37.5 mg | ➤ Subscribe | 2009-05-19 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
